XML 22 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Share-based Compensation
3 Months Ended
Mar. 31, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
5.
 
SHARE-BASED COMPENSATION
 
The Company measures and recognizes compensation expense for all share-based payments based on the grant-date fair value of those awards. All of the Company
’s existing stock option awards and unvested stock awards have been determined to be equity-classified awards.
 
The Company
’s
2001
Equity Incentive Plan provided for the granting of stock options, stock appreciation rights, restricted stock, performance shares and other share-based awards and benefits up to an aggregate of
1,800,000
shares of class A common stock and
300,000
shares of class B common stock. Stock options granted could have been either nonqualified or incentive stock options. Stock options vest over
one
to
five
years following the date of grant and option terms are generally
five
to
ten
years following the date of grant.
 
The Company
’s
2004
Non-Employee Director Stock Plan, as amended (the
“2004
Director Plan”), is a nonqualified plan that provides for the granting of options with respect to
3,000,000
shares of class A common stock and
500,000
shares of class B common stock. The
2004
Director Plan provides for grants of nonqualified stock options to each director of the Company who is not employed by the Company. On the date of each annual meeting of shareholders of the Company, options to purchase
36,000
shares of class A common stock and
6,000
shares of class B common stock are granted to directors that are elected or retained as a director at such meeting. Stock options vest
one
year following the date of grant and option terms are generally
ten
years following the date of grant, or
three
years in the case of termination of the outside director’s service.
 
The Company
’s
2006
Equity Incentive Plan provides for the granting of stock options, stock appreciation rights, restricted stock, performance shares and other share-based awards and benefits up to an aggregate of
1,800,000
shares of class A common stock and
300,000
shares of class B common stock. Stock options granted
may
be either incentive stock options or nonqualified stock options. Vesting terms vary with each grant and option terms are generally
five
to
ten
years following the date of grant.
 
The Company granted options to purchase
119,917
shares of the Company’s class A common stock and
19,986
shares of the class B common stock during the
three
-month period ended
March
31,
2017.
Options to purchase shares of common stock were granted with exercise prices equal to the fair value of the common stock on the date of grant. The fair value of the stock options granted was estimated using a Black-Scholes valuation model with the following assumptions:
 
   
201
7
   
201
6
 
   
Class A
   
Class B
   
Class A
   
Class B
 
Expected dividend yield at date of grant
   
2.87
%    
7.99
%    
3.02
%    
8.12
%
Expected stock price volatility
   
32.20
%    
27.18
%    
34.61
%    
31.77
%
Risk-free interest rate
   
2.33
%    
2.33
%    
2.12
%    
2.12
%
Expected life of options (in years)
   
8
     
8
     
8
     
8
 
 
The risk-free interest rate assumptions were based on the U.S. Treasury yield curve in effect at the time of the grant. The expected volatility was based on historical monthly price changes of the Company
’s common stock based on the expected life of the options at the date of grant. The expected life of options is the average number of years the Company estimates that options will be outstanding. The Company considers groups of associates that have similar historical exercise behavior separately for valuation purposes.
 
The following table summarizes stock option activity under the Company
’s
2001
and
2006
Equity Incentive Plans and the
2004
Director Plan for the
three
months ended
March
31,
2017:
 
   
Number of
Options
   
Weighted
Average
Exercise
Price
   
Weighted Average
Remaining
Contractual
Terms
(Years)
   
Aggregate
Intrinsic
Value
(In
thousands)
 
Class A
                               
Outstanding at December 31, 201
6
   
1,705,483
    $
12.31
     
 
     
 
 
Granted
   
119,917
    $
18.80
     
 
     
 
 
Exercised
   
(97,068
)   $
13.10
     
 
    $
590
 
Forfeit
ed
   
--
     
--
     
 
     
 
 
Outstanding at
March 31, 2017
   
1,728,332
    $
12.72
     
6.00
    $
12,064
 
Exercisable at
March 31, 2017
   
1,195,077
    $
11.49
     
4.76
    $
9,807
 
Class B
                               
Outstanding at
December 31, 2016
   
250,493
    $
29.70
     
 
     
 
 
Granted
   
19,986
    $
40.54
     
 
     
 
 
Exercised
   
(12,000
)   $
28.41
     
 
    $
142
 
Forfeited
   
--
     
--
     
 
     
 
 
Outstanding at
March 31, 2017
   
258,479
    $
30.60
     
6.38
    $
2,402
 
Exercisable at
March 31, 2017
   
170,550
    $
27.52
     
5.14
    $
2,140
 
 
As of
March
31,
2017,
the total unrecognized compensation cost related to non-vested stock option awards was approximately
$1.2
million and
$179,000
for class A and class B common shares, respectively, which is expected to be recognized over a weighted average period of
3.86
years and
3.57
years for class A and class B common stock shares, respectively.
 
The following table summarizes information regarding non-
vested stock granted to associates under the
2001
and
2006
Equity Incentive Plan for the
three
months ended
March
31,
2017:
 
   
Class A
Shares
Outstanding
   
Class A
Weighted
Average
Grant Date
Fair Value
Per Share
   
Class B
Shares
Outstanding
   
Class B
Weighted
Average
Grant Date
Fair Value
Per Share
 
Outstanding at
December 31, 2016
   
174,487
    $
13.93
     
29,081
    $
37.21
 
Granted
   
--
     
--
     
--
     
--
 
Vested
   
--
     
--
     
--
     
--
 
Forfeited
   
--
     
--
     
--
     
--
 
Outstanding at
March 31, 2017
   
174,487
    $
13.93
     
29,081
    $
37.21
 
 
As of
March
31,
2017,
the total unrecognized compensation cost related to non-vested stock awards was approximately
$1.6
million and is expected to be recognized over a weighted average period of
2.88
years.